Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5384-5393

  Shan, Liang ^a   Yang, Hung Chih ^a,c   Rabi, S Alireza ^a   Bravo, Hector C ^a   Shroff, Neeta S ^c   Irizarry, Rafael A ^a   Zhang, Hao ^b   Margolick, Joseph B ^b   Siliciano, Janet D ^a   Siliciano, Robert F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRON; NONHUMAN; PRIORITY JOURNAL; SERIAL ANALYSIS OF GENE EXPRESSION; UPREGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79956082418     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02536-10     Document Type: Article

References (63)

1. Adhya, S., and M. Gottesman. 1982. Promoter occlusion: transcription through a promoter may inhibit its activity. Cell 29:939-944.
2. Blazkova, J., et al. 2009. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5:e1000554. doi:10.1371/journal.ppat.1000554.
3. Bohnlein, E., et al. 1988. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53:827-836.
4. Bosque, A., and V. Planelles. 2009. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113:58-65. doi:10.1182/blood-2008-07-168393.
5. Brooks, D. G., S. G. Kitchen, C. M. Kitchen, D. D. Scripture-Adams, and J. A. Zack. 2001. Generation of HIV latency during thymopoiesis. Nat. Med. 7:459-464. doi:10.1038/86531.
6. Callen, B. P., K. E. Shearwin, and J. B. Egan. 2004. Transcriptional interference between convergent promoters caused by elongation over the promoter. Mol. Cell 14:647-656. doi:10.1016/j.molcel.2004.05.010.
7. Chun, T. W., et al. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284-1290.
8. Chun, T. W., et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188. doi:10.1038/387183a0.
9. Chun, T. W., et al. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 94:13193-13197.
10. Chun, T. W., et al. 2003. Gene expression and viral production in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc. Natl. Acad. Sci. U. S. A. 100:1908-1913. doi:10.1073/pnas.0437640100.
11. Coull, J. J., et al. 2000. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74:6790-6799.
12. Cujec, T. P., et al. 1997. The HIV transactivator TAT binds to the CDKactivating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:2645-2657.
13. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. U. S. A. 86:5974-5978.
14. Finzi, D., et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
15. Finzi, D., et al. 1999. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517. doi:10.1038/8394.
16. Ganesh, L., et al. 2003. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426:853-857. doi:10.1038/nature02171.
17. Greger, I. H., F. Demarchi, M. Giacca, and N. J. Proudfoot. 1998. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res. 26:1294-1301.
18. Han, Y., et al. 2004. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78:6122-6133. doi:10.1128/JVI.78.12.6122-6133.2004.
19. Han, Y., M. Wind-Rotolo, H. C. Yang, J. D. Siliciano, and R. F. Siliciano. 2007. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5:95-106. doi:10.1038/nrmicro1580.
20. Han, Y., et al. 2008. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4:134-146. doi:10.1016/j.chom.2008.06.008.
21. He, G., and D. M. Margolis. 2002. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol. Cell. Biol. 22:2965-2973.
22. Hermankova, M., et al. 2003. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J. Virol. 77:7383-7392.
23. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
24. Huang, J., et al. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13:1241-1247. doi:10.1038/nm1639.
25. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743. doi: 10.1146/annurev.bi.63.070194.003441.
26. Joos, B., et al. 2008. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl. Acad. Sci. U. S. A. 105: 16725-16730. doi:10.1073/pnas.0804192105.
27. Jordan, A., D. Bisgrove, and E. Verdin. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22:1868-1877. doi:10.1093/emboj/cdg188.
28. Jordan, A., P. Defechereux, and E. Verdin. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20:1726-1738. doi:10.1093/emboj/20.7.1726.
29. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493. doi:10.1038/330489a0.
30. Kauder, S. E., A. Bosque, A. Lindqvist, V. Planelles, and E. Verdin. 2009. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5:e1000495. doi:10.1371/journal.ppat.1000495.
31. Kinoshita, S., et al. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235-244.
32. Lassen, K., Y. Han, Y. Zhou, J. Siliciano, and R. F. Siliciano. 2004. The multifactorial nature of HIV-1 latency. Trends Mol. Med. 10:525-531. doi: 10.1016/j.molmed.2004.09.006.
33. Lassen, K. G., K. X. Ramyar, J. R. Bailey, Y. Zhou, and R. F. Siliciano. 2006. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2:e68. doi:10.1371/journal.ppat.0020068.
34. Lenasi, T., X. Contreras, and B. M. Peterlin. 2008. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe 4:123-133. doi:10.1016/j.chom.2008.05.016.
35. Lewinski, M. K., et al. 2005. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79:6610-6619. doi:10.1128/JVI.79.11.6610-6619.2005.
36. Liu, H., et al. 2006. Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J. Virol. 80:7765-7768. doi:10.1128/JVI.00542-06.
37. Marini, A., J. M. Harper, and F. Romerio. 2008. An in vitro system to model the establishment and reactivation of HIV-1 latency. J. Immunol. 181:7713-7720.
38. Martens, J. A., L. Laprade, and F. Winston. 2004. Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 429: 571-574. doi:10.1038/nature02538.
39. Mazo, A., J. W. Hodgson, S. Petruk, Y. Sedkov, and H. W. Brock. 2007. Transcriptional interference: an unexpected layer of complexity in gene regulation. J. Cell Sci. 120:2755-2761. doi:10.1242/jcs.007633.
40. Mochizuki, H., J. P. Schwartz, K. Tanaka, R. O. Brady, and J. Reiser. 1998. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72:8873-8883.
41. Morrissy, A. S., et al. 2009. Next-generation tag sequencing for cancer gene expression profiling. Genome Res. 19:1825-1835. doi:10.1101/gr.094482.109.
42. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713. doi:10.1038/326711a0.
43. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
44. Prescott, E. M., and N. J. Proudfoot. 2002. Transcriptional collision between convergent genes in budding yeast. Proc. Natl. Acad. Sci. U. S. A. 99:8796-8801. doi:10.1073/pnas.132270899.
45. Sahu, G. K., et al. 2006. A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. Virology 355:127-137. doi:10.1016/j.virol.2006.07.020.
46. Schroder, A. R., et al. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529.
47. Selby, M. J., and B. M. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776.
48. Shearwin, K. E., B. P. Callen, and J. B. Egan. 2005. Transcriptional interference- a crash course. Trends Genet. 21:339-345. doi:10.1016/j.tig.2005.04.009.
49. Siliciano, J. D., et al. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9:727-728. doi:10.1038/nm880.
50. Strain, M. C., et al. 2003. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. U. S. A. 100:4819-4824. doi:10.1073/pnas.0736332100.
51. Tyagi, M., R. J. Pearson, and J. Karn. 2010. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J. Virol. 84:6425-6437. doi:10.1128/JVI.01519-09.
52. Van Lint, C., S. Emiliani, M. Ott, and E. Verdin. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-1120.
53. Vatakis, D. N., S. Kim, N. Kim, S. A. Chow, and J. A. Zack. 2009. Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. J. Virol. 83:6222-6233. doi:10.1128/JVI.00356-09.
54. Velculescu, V. E., L. Zhang, B. Vogelstein, and K. W. Kinzler. 1995. Serial analysis of gene expression. Science 270:484-487.
55. Verdin, E., P. Paras, Jr., and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-3259.
56. Wang, S. M. 2007. Understanding SAGE data. Trends Genet. 23:42-50. doi:10.1016/j.tig.2006.11.001.
57. Weinberger, L. S., J. C. Burnett, J. E. Toettcher, A. P. Arkin, and D. V. Schaffer. 2005. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122:169-182. doi:10.1016/j.cell.2005.06.006.
58. West, M. J., A. D. Lowe, and J. Karn. 2001. Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation. J. Virol. 75:8524-8537.
59. Williams, S. A., et al. 2006. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139-149. doi:10.1038/sj.emboj.7600900.
60. Williams, S. A., and W. C. Greene. 2007. Regulation of HIV-1 latency by T-cell activation. Cytokine 39:63-74. doi:10.1016/j.cyto.2007.05.017.
61. Wong, J. K., et al. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
62. Yang, H. C., et al. 2009. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J. Clin. Invest. 119:3473-3486. doi:10.1172/JCI39199.
63. Zhang, L., et al. 2000. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Invest. 106:839-845. doi:10.1172/JCI10565.